Russian scientists develop algorithm for anti-aging remedy search

May 15, 2014
Credit: Moscow Institute of Physics and Technology

MIPT scientists have provided an algorithm which can help in the search for aging-suppressing drugs. The researchers, whose work is published in Frontiers in Genetics magazine, have compared gene expression in young and elderly patients' cells.

The scientists – Alexander Zhavoronkov, Anton Buzdin, Andrey Garazha, Nickolay Borisov and Alexey Moskalev– have based the new research on their previously-developed methods in the study of . Each cell uses particular schemes of , which physiologists call intercellular signaling pathways.

A is a chain of sequential events of interaction between certain molecules which make the cell respond to stimulation. For example, hormone molecules first interact with the cell's membrane receptors, then the receptors engage with the molecules inside the cell, and those, in turn, deliver the signal into the cell's nucleus. As a result, inside the nucleus there occur changes in the way certain proteins engage with DNA and in the expression of genes. This leads to changes in the synthesis of RNA molecules, which are responsible for protein-producing processes.

Events in a cell's life-cycle can be roughly of two types: normal (such as hormone-induced response or performance of certain functions related to body growth) and abnormal, or pathological (i.e., malignant degeneration). Both these types of events are accompanied by changes in signaling pathway activity. What is more important, the same chain of reactions can be traced in totally different processes, i.e., there is no such thing as a "malignant cell forming protein", or a "long-term memory protein".

The team of experts from MIPT and other Russian and British organizations (the full list of names can be found in the article) suggested comparing peculiarities of signaling pathways activation in young and aging cells. This information is then expanded with the available data on the impact of various substances on signaling pathways.

Thus, the new algorithm helps to predict the type of change in the profile of intracellular molecular interaction which will occur in response to this or that drug.

In their article the scientists point out that their algorithm can be used in rapid and inexpensive search for drugs which can minimize the difference between the of young and . This means that it will be possible to speed up the search for longevity drugs and decrease its cost. What is more, this will be achieved not by simply fighting some particular diseases, but by a complex influence on the mechanisms of aging.

Explore further: Combo method reveals cells' signal systems

More information: Paper: journal.frontiersin.org/Journal/10.3389/fgene.2014.00049/full

Related Stories

Combo method reveals cells' signal systems

May 25, 2011

Our understanding of what differentiates cancer cells from normal cells is limited by a lack of methods for studying the complex signal systems of individual cells. By combing two different methods, a team of Uppsala researchers ...

How DNA damage affects Golgi—the cell's shipping department

January 30, 2014

In studying the impact of DNA damage on the Golgi, a research team from the University of California, San Diego School of Medicine and the Ludwig Institute for Cancer Research have discovered a novel pathway activated by ...

Researchers examine metabolism in defective cells

April 11, 2014

University of Alberta researchers are taking a closer look at how two metabolic pathways interact to increase the lifespan of cells with mitochondrial defects. Magnus Friis is the lead author of the study, which was published ...

Recommended for you

Solving the mystery of meningiomas reveals a surprise twist

August 23, 2016

In solving one mystery—the genetic roots of benign brain tumors called meningiomas—a team of scientists led by Yale researchers stumbled upon an even greater one: How is it possible that two of the mutations linked to ...

Two key proteins preserve vital genetic information

August 22, 2016

Cancer is often driven by various genetic mutations that are acquired through changes to a person's DNA over time. These alterations can occur at the chromosome level if the proteins are not properly organized and segregated ...

Team identifies genes responsible for CMD risk

August 18, 2016

In a study being published in the August 19 issue of Science, researchers from the Icahn School of Medicine at Mount Sinai, in collaboration with scientists from Tartu University Hospital in Estonia, the Karolinska Institutet ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.